Since memory impairment represents the distinctive feature of Alzheimer's disease (AD) [3], some studies have investigated biological AD hallmarks in relation to cognitive symptoms in ALS patients and the possible involvement of Aβ and tau proteins in ALS pathophysiology [4]. This evidence concerns the gene MAPT and amyotrophic lateral sclerosis.